Cargando…

Molecular Genetics in Neuroblastoma Prognosis

In recent years, much research has been carried out to identify the biological and genetic characteristics of the neuroblastoma (NB) tumor in order to precisely define the prognostic subgroups for improving treatment stratification. This review will describe the major genetic features and the recent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lerone, Margherita, Ognibene, Marzia, Pezzolo, Annalisa, Martucciello, Giuseppe, Zara, Federico, Morini, Martina, Mazzocco, Katia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226597/ https://www.ncbi.nlm.nih.gov/pubmed/34072462 http://dx.doi.org/10.3390/children8060456

Ejemplares similares

19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
por: Lasorsa, Vito Alessandro, et al.
Publicado: (2020)

Neuroblastoma Patients’ Outcome and Chromosomal Instability
por: Ognibene, Marzia, et al.
Publicado: (2023)

Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis
por: Ognibene, Marzia, et al.
Publicado: (2023)

Roniciclib down-regulates stemness and inhibits cell growth by inducing nucleolar stress in neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2020)

Ezrin interacts with the tumor suppressor CHL1 and promotes neuronal differentiation of human neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2020)

High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene TSSC1
por: Ognibene, Marzia, et al.
Publicado: (2021)

Role of GOLPH3 and TPX2 in Neuroblastoma DNA Damage Response and Cell Resistance to Chemotherapy
por: Ognibene, Marzia, et al.
Publicado: (2019)

Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells
por: Degli Esposti, Chiara, et al.
Publicado: (2021)

Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4
por: Ognibene, Marzia, et al.
Publicado: (2022)

The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease
por: Parodi, Stefano, et al.
Publicado: (2020)

Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors
por: Veneziani, Irene, et al.
Publicado: (2018)

CHL1 gene acts as a tumor suppressor in human neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2018)

Surgical Advances in Paediatric Neuroblastoma
por: Martucciello, Giuseppe
Publicado: (2022)

A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers
por: Ognibene, Marzia, et al.
Publicado: (2023)

Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors
por: Ognibene, Marzia, et al.
Publicado: (2017)

Surgical Approaches to Neuroblastoma: Review of the Operative Techniques
por: Fati, Federica, et al.
Publicado: (2021)

Multiple endocrine neoplasias type 2B and RET proto-oncogene
por: Martucciello, Giuseppe, et al.
Publicado: (2012)

Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome
por: Brandetti, Elisa, et al.
Publicado: (2021)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment
por: Czapiewski, Piotr, et al.
Publicado: (2016)

The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma
por: Grasso, Silvia, et al.
Publicado: (2019)

Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study (‖)
por: Morini, Martina, et al.
Publicado: (2019)

Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants
por: Dondero, Alessandra, et al.
Publicado: (2021)

Intratumoral diversity of telomere length in individual neuroblastoma tumors
por: Pezzolo, Annalisa, et al.
Publicado: (2014)

Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants
por: Bottino, Cristina, et al.
Publicado: (2022)

The Cervico-Parasternal Thoracotomy (CPT): A New Surgical Approach for the Resection of Cervicothoracic Neuroblastomas
por: Martucciello, Giuseppe, et al.
Publicado: (2021)

Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas
por: Cantilena, Sandra, et al.
Publicado: (2011)

The Role of Biopsy in the Workup of Patients with Neuroblastoma: Comparison of the Incidence of Surgical Complications and the Diagnostic Reliability of Diverse Techniques
por: Paraboschi, Irene, et al.
Publicado: (2021)

Proteome Profiling of Neuroblastoma-Derived Exosomes Reveal the Expression of Proteins Potentially Involved in Tumor Progression
por: Marimpietri, Danilo, et al.
Publicado: (2013)

Stage 4 s neuroblastoma: features, management and outcome of 268 cases from the Italian Neuroblastoma Registry
por: De Bernardi, Bruno, et al.
Publicado: (2019)

Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy
por: Pistoia, Vito, et al.
Publicado: (2016)

Genetic Predisposition to Neuroblastoma
por: Barr, Erin K., et al.
Publicado: (2018)

Genetic aberrations and molecular biology of cardiac sarcoma
por: Urbini, Milena, et al.
Publicado: (2020)

Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma
por: López-Carrasco, Amparo, et al.
Publicado: (2021)

Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming
por: Cangelosi, Davide, et al.
Publicado: (2020)

Molecularly Targeted Therapy for Neuroblastoma
por: Greengard, Emily G.
Publicado: (2018)

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
por: Berbegall, Ana P., et al.
Publicado: (2018)

MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma
por: Brandetti, Elisa, et al.
Publicado: (2017)

Untargeted LC-HRMS Based-Plasma Metabolomics Reveals 3-O-Methyldopa as a New Biomarker of Poor Prognosis in High-Risk Neuroblastoma
por: Barco, Sebastiano, et al.
Publicado: (2022)

Artificial neural network classifier predicts neuroblastoma patients’ outcome
por: Cangelosi, Davide, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i12b45vsk3pna1vp07cbm88q6d